Association between metabolic comorbidities and retention rates of first-line b/tsDMARD treatment in patients with psoriatic arthritis: European real-world results
24/11/2025
Faizy Z. et al (EurpSpA)
https://scientific.sparx-ip.net/archiveeular/?c=a&searchfor=biobadaser&view=1&item=2025POS1250
EULAR 2025